CAS RN: 1251083-96-1
Cyclopropyl-piperidin-3-yl-amine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250807
1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1251083-96-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1251083-96-1 / N-cyclopropylpiperidin-3-amine
Standard CAS: 1251083-96-1
Multi CAS: No
Basic Information
copy
CAS
1251083-96-1 copy
Multi CAS
No copy
Molecular Formula
C8H16N2 copy
Molecular Weight
140.230000 copy
Exact Mass
140.131349 copy
SMILES
C1CC(CNC1)NC2CC2 copy
InChI
InChI=1S/C8H16N2/c1-2-8(6-9-5-1)10-7-3-4-7/h7-10H,1-6H2 copy
InChIKey
ZMIGJHHQCUHNJJ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Fraction Csp3
1 copy
Rotatable bonds
2 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
42.05 copy
TPSA
24.06 copy
LogP / Solubility
WLOGP
0.49 copy
MLOGP
0.42 copy
XLogP3
0.5 copy
Consensus LogP
0.47 copy
Log S (ESOL)
-0.89 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
-1.06 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.22 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.23 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy